Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew B Stern

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Expert Review of Neurotherapeutics|June 15, 2007
Intervening in the neuropsychiatric features of Parkinson's diseaseDaniel Weintraub, Matthew B Stern
Expert Review of Neurotherapeutics|December 15, 2012
New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implicationsRizwan S Akhtar, Matthew B Stern
Current Neurology and Neuroscience Reports|August 20, 2013
Medication nonadherence in Parkinson's diseaseJori E Fleisher, Matthew B Stern
Current Opinion in Neurology|April 6, 2011
Diagnostic markers for Parkinson's diseaseLama M Chahine, Matthew B Stern
Neurology|March 23, 2002
Dopamine agonists and sleep in Parkinson's diseaseCharles R Cantor, Matthew B Stern
Movement Disorders Clinical Practice|October 27, 2018
Characterizing Premotor Parkinson's Disease: Clinical Features and Objective MarkersLama M Chahine, Matthew B Stern
Movement Disorders Clinical Practice|October 27, 2018
Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?Lana M Chahine, Matthew B Stern
Annals of Neurology|January 8, 2009
Parkinson's disease: unresolved issuesC Warren Olanow, Matthew B Stern
Movement Disorders : Official Journal of the Movement Disorder Society|October 31, 2009
Premotor Parkinson's disease: clinical features and detection strategiesRandolph Stephenson, Andrew Siderowf, Matthew B Stern
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 2007
Effect of age on geriatric depression scale performance in Parkinson's diseaseDaniel Weintraub, Kirsten Saboe, Matthew B Stern
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Expert Review of Neurotherapeutics|June 15, 2007
Intervening in the neuropsychiatric features of Parkinson's diseaseDaniel Weintraub, Matthew B Stern
Expert Review of Neurotherapeutics|December 15, 2012
New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implicationsRizwan S Akhtar, Matthew B Stern
Current Neurology and Neuroscience Reports|August 20, 2013
Medication nonadherence in Parkinson's diseaseJori E Fleisher, Matthew B Stern
Current Opinion in Neurology|April 6, 2011
Diagnostic markers for Parkinson's diseaseLama M Chahine, Matthew B Stern
Neurology|March 23, 2002
Dopamine agonists and sleep in Parkinson's diseaseCharles R Cantor, Matthew B Stern
Movement Disorders Clinical Practice|October 27, 2018
Characterizing Premotor Parkinson's Disease: Clinical Features and Objective MarkersLama M Chahine, Matthew B Stern
Movement Disorders Clinical Practice|October 27, 2018
Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?Lana M Chahine, Matthew B Stern
Annals of Neurology|January 8, 2009
Parkinson's disease: unresolved issuesC Warren Olanow, Matthew B Stern
Movement Disorders : Official Journal of the Movement Disorder Society|October 31, 2009
Premotor Parkinson's disease: clinical features and detection strategiesRandolph Stephenson, Andrew Siderowf, Matthew B Stern
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 2007
Effect of age on geriatric depression scale performance in Parkinson's diseaseDaniel Weintraub, Kirsten Saboe, Matthew B Stern
Pageof 9